FDA Adverse Event Injury Summary report: N

TAXUS? LIBERTÉ?

MDR report key: 4202430 · Received October 27, 2014

Report

Report Number
2134265-2014-06410
Event Type
Injury
Date Received
October 27, 2014
Date of Event
May 14, 2014
Report Date
September 29, 2014
Manufacturer
BOSTON SCIENTIFIC - GALWAY
Product Code
NIQ
PMA / PMN Number
P060008
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
SY
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

EVENT DATE CORRECTED FROM (B)(6) 2014 TO (B)(6) 2014. DESCRIBE EVENT OR PROBLEM UPDATED, DEVICE EVALUATED BY MFR., EVAL SUMMARY ATTACHED, METHOD CODES, RESULT CODES, CONCLUSION CODES UPDATED. DEVICE EVALUATED BY MFR.: THE STENT DELIVERY SYSTEM (SDS) WAS RETURNED FOR ANALYSIS. THE BALLOON CONE PROFILES WERE REVIEWED AND NO ISSUES WERE NOTED WITH THE OVERALL BALLOON PROFILE. THE CRIMPED STENT WAS DETACHED FROM BALLOON AND NOT RETURNED WITH DEVICE FOR ANALYSIS. CRIMP MARKINGS WERE EVIDENT ON THE WALL OF THE BALLOON INDICATING THAT FULL CRIMP CONTACT WAS ACHIEVED BETWEEN THE STENT AND BALLOON. A VISUAL AND TACTILE EXAMINATION FOUND NO ISSUES WITH THE HYPOTUBE SHAFT PROFILE. THE BUMPER TIP OF THE DEVICE SHOWED NO SIGNS OF DAMAGE. A VISUAL AND TACTILE EXAMINATION FOUND NO ISSUES WITH THE PROFILE OF THE SHAFT. THE MANUFACTURING BATCH RECORD REVIEW CONFIRMED THAT THE DEVICE MET ALL MATERIAL, ASSEMBLY AND PERFORMANCE SPECIFICATIONS. THE MOST PROBABLE ROOT CAUSE IS OPERATIONAL CONTEXT AS DEVICE PERFORMANCE WAS LIMITED DUE TO ANATOMICAL/ PROCEDURAL FACTORS. (B)(4).

Additional Manufacturer Narrative · 1

(B)(4).

Description of Event or Problem · 1

IT WAS REPORTED THAT STENT DISLODGEMENT OCCURRED. THE PATIENT PRESENTED WITH MYOCARDIAL INFARCTION. VASCULAR ACCESS WAS OBTAINED VIA FEMORAL ARTERY. THE 80% STENOSED, 16X2.75MM, CONCENTRIC, DE NOVO TARGET LESION WAS LOCATED IN THE MODERATELY TORTUOUS AND NON-CALCIFIED LEFT ANTERIOR DESCENDING (LAD) ARTERY. PRE-DILATION WAS PERFORMED WITH A NON-BSC BALLOON CATHETER. FOLLOWING PRE-DILATION, RESIDUAL STENOSIS WAS 70%. A 16 X 2.75MM TAXUS¿ LIBERTÉ¿ DRUG-ELUTING STENT WAS ADVANCED TO TREAT THE LESION. IT WAS NOTED THAT THE DEVICE ENTERED THE BODY TWICE AND THERE WAS RESISTANCE DURING ADVANCING AND REPOSITIONING. THE STENT WAS DEPLOYED AT 12 ATMS FOR 12 SECONDS AND WAS NOTED TO BE FULLY EXPANDED. HOWEVER, THE STENT DISLODGED AND EMBOLIZED TO THE ILIAC ARTERY. NO ATTEMPTS WERE MADE TO RETRIEVE THE STENT. THE PROCEDURE WAS NOT COMPLETED; THE PATIENT WILL BE UNDER OBSERVATION. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED AND PATIENT'S STATUS WAS STABLE.

Description of Event or Problem · 1

IT WAS FURTHER REPORTED THAT THE STENT WAS NOT DEPLOYED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
681762 TAXUS? LIBERTÉ? CORONARY DRUG-ELUTING STENT NIQ BOSTON SCIENTIFIC - GALWAY H7493894016270 16455260

Patients

Seq Age Sex Outcome Treatment
1 60 YR Hospitalization| O POWER LINE 1.5X 20= BALLOON| 6F MACH1 / FL4= GUIDE CATHETER| BMW ¿ MODERATE= GUIDE WIRE